Medical Professional Publications

Pharmacy and Therapeutics Committee Updates

(From the April 2017 Issue of MedStat)

The following actions were taken at the 3/2/17 Pharmacy & Therapeutics Committee meeting:

Standardized dosing for infliximab and infliximab-DYYB was APPROVED

Medication stock list was APPROVED for Neurology Clinic on main campus

Medication Samples were APPROVED for Rheumatology Clinic for golimumab, tocilizumab, and canakinumab

Abobotulinumtoxin A (Dysport®) was ADDED to formulary

Ciprofloxacin otic suspension (Otiprio®) was ADDED to formulary with a restriction to otolaryngology

Propranolol IV Administration Guidelines were APPROVED with removal of requirements for blood glucose monitoring

myChildren’s mobile app

iPhone and Android.

Download Today! »

Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000